The objective of this application is to determine how p-catenin signaling is regulated by EGF-induced tyrosine phosphorylation of the p-catenin protein. Aberrant activation of Wnt/p-catenin signaling plays an important role in tumorigenesis. We have found that p-catenin signaling is frequently activated in human osteosarcoma. Many receptor tyrosine kinases (e.g., EGFR) and non-receptor tyrosine kinases (e.g., Src) are up-regulated in cancer cells. We previously reported that p-catenin signaling can be inhibited by tyrosine kinase inhibitor STI-571/Gleevec and EGFR inhibitor AG-1478. We have recently demonstrated that EGF activates p-catenin signaling and induces tyrosine phosphorylation of the C-terminal region of P-catenin. The importance of tyrosine phosphorylation in Wnt/p-catenin signaling has further been highlighted by a recent discovery, in which an atypical receptor tyrosine kinase Ryk has been shown to be a Wnt coreceptor and is required for WntSa-induced neurite outgrowth. However, the mechanisms behind the regulatory role of tyrosine phosphorylation in p-catenin signaling are unknown. We hypothesize that tyrosine phosphorylation of p-catenin can induce conformational changes which affect the interactions of p-catenin with its binding partners, resulting in an increased association with factorsthat enhance p-catenin-mediated transactivation. In this application, we propose to use EGF-induced phosphorylation as an exemplary systemto dissect the regulatory mechanisms behind tvrosine phosphorylation in B-catenin signaling by focusing on the following three aims.
The first aim i s to determine the EGF-induced tyrosine phosphorylation site(s) ofP- catenin by using immunoprecipitation/phosphotyrosine Western blotting, EGFR in vitro phosphorylation assays, and mass spectral analysis.
The second aim i s to determine whether EGF regulates the interactions of P-catenin with its C-terminal binding partners ICAT and p300, by using immunoprecipitation and FRET protein interaction analysis.
The third aim i s to determine whether tyrosine mutants of p-catenin affect canonical Wnt signal-induced axis duplication in Xenopus embryos and tumor growth in mousexenograft tumor models. We believe that results from the proposed studies should expand our knowledge about the functional role of tyrosine phosphorylation in regulating the p-catenin signaling activity. Because both deregulation of p-catenin signaling and elevation of tyrosine kinase activities are common in human cancer, successful execution of this application should increase our knowledge about p-catenin signaling in cancer development, and may lead to the development of innovative strategiesfor cancer treatment and prevention by targeting both tyrosine kinases and p-catenin signaling pathways.
|Uchiyama, Kazuhiko; Sakiyama, Toshio; Hasebe, Takumu et al. (2016) Butyrate and bioactive proteolytic form of Wnt-5a regulate colonic epithelial proliferation and spatial development. Sci Rep 6:32094|
|Yan, Zhengjian; Yin, Liangjun; Wang, Zhongliang et al. (2016) A Novel Organ Culture Model of Mouse Intervertebral Disc Tissues. Cells Tissues Organs 201:38-50|
|Mohammed, Maryam K; Shao, Connie; Wang, Jing et al. (2016) Wnt/Î²-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance. Genes Dis 3:11-40|
|Yang, Ke; Wang, Xin; Zhang, Hongmei et al. (2016) The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies. Lab Invest 96:116-36|
|Shao, Connie; Shen, Christine; Lu, Emily et al. (2015) Damage control: Harnessing prostaglandin E2 as a potential healing factor of tissue injuries. Genes Dis 2:295-298|
|Hu, Jim; He, Tong-Chuan; Li, Fei (2015) For your eyes only: Harnessing human embryonic stem cell-derived retinal pigment epithelial cells to improve impaired vision. Genes Dis 2:293-294|
|Li, Fei; Hu, Jim; Xie, Keping et al. (2015) Authentication of experimental materials: A remedy for the reproducibility crisis? Genes Dis 2:283|
|Wang, Jing; Wei, Qiang; Ye, Jixing et al. (2015) Insider information: Testing cancer drug sensitivity for personalized therapy. Genes Dis 2:219-221|
|Green, Jordan D; Tollemar, Viktor; Dougherty, Mark et al. (2015) Multifaceted signaling regulators of chondrogenesis: Implications in cartilage regeneration and tissue engineering. Genes Dis 2:307-327|
|Zhang, Yunyuan; Chen, Xian; Qiao, Min et al. (2014) Bone morphogenetic protein 2 inhibits the proliferation and growth of human colorectal cancer cells. Oncol Rep 32:1013-20|
Showing the most recent 10 out of 42 publications